You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adult Refsum

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients With Peroxisome Biogenesis Disorders (PBD)

Recruiting
  • Peroxisome Biogenesis Disorder
  • +10 more
    • Montreal, Quebec, Canada
      Research Institute of the McGill University Health Center
    Jul 4, 2022

    Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

    Recruiting
    • Rare Disorders
    • +309 more
      • Sioux Falls, South Dakota
      • +1 more
      Jun 20, 2022

      A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J)

      Terminated
      • Charcot-Marie-Tooth Disease
      • Hereditary Motor and Sensory Neuropathy IV
        • Iowa City, Iowa
        • +1 more
        Mar 16, 2022

        Clinical Outcome of Treatment of Ulcerative Colitis in Adult

        Not yet recruiting
        • Ulcerative Colitis
          • (no location specified)
          Nov 20, 2023

          T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)

          Completed
          • T2DM (Type 2 Diabetes Mellitus)
          • Beijing, Beijing, China
            Peking Union Medical College Hospital
          Aug 1, 2023

          Severity in Juvenile and Adult-onset Dermatomyositis

          Not yet recruiting
          • Dermatomyositis
          • evaluation of clinical severity
          • (no location specified)
          Aug 16, 2023

          Suture Trial in Hong Kong (Virtual reality)

          Recruiting
          • Suture
          • Virtual reality
          • Hong Kong, Hong Kong
            Tuen Mun Hospital-Emergency department
          Mar 21, 2023

          Chronic Hepatitis b Trial in Wuhan (TQA3038 injection, TQA3038 injection matching )

          Not yet recruiting
          • Chronic Hepatitis b
          • TQA3038 injection
          • TQA3038 injection matching placebo
          • Wuhan, Hubei, China
            Tongji Hospital
          Oct 17, 2023

          Still's Disease, Juvenile Onset, Still's Disease, Adult-Onset Trial in Japan (Anakinra, Placebo)

          Recruiting
          • Still's Disease, Juvenile Onset
          • Still's Disease, Adult-Onset
          • Chiba-shi, Chiba, Japan
          • +17 more
          Apr 3, 2023

          Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)

          Recruiting
          • Healthy Adult Subjects
          • San Antonio, Texas
            ICON Early Phase Services
          Oct 24, 2023

          Electronic Cigarette Use, E-Cig Use, Cigarette Smoking Trial in Los Angeles (E-cigarette e-liquid self-administration)

          Completed
          • Electronic Cigarette Use
          • +3 more
          • E-cigarette e-liquid self-administration
          • Los Angeles, California
            University of Southern California
          Jul 14, 2023

          Pulmonary Arterial Hypertension Trial (PF-07868489, Placebo for PF-07868489)

          Not yet recruiting
          • Pulmonary Arterial Hypertension
          • (no location specified)
          Nov 14, 2023

          Bleeding Disorder Trial in Charlottesville (Recombinant von Willebrand Factor)

          Not yet recruiting
          • Bleeding Disorder
          • Recombinant von Willebrand Factor
          • Charlottesville, Virginia
            UVA Hospital
          Nov 3, 2023

          Healthy Trial (Drug: PF-07817883)

          Not yet recruiting
          • Healthy
          • Drug: PF-07817883
          • (no location specified)
          Nov 2, 2023

          Alzheimer Trial in Arlington (Reminiscence with digital storytelling, Social wellness with scrapbook or journal)

          Completed
          • Alzheimer Disease
          • Reminiscence with digital storytelling
          • Social wellness with scrapbook or journal
          • Arlington, Texas
            The University of Texas at Arlington
          Aug 7, 2023

          Social Isolation, Loneliness, Intergenerational Relations Trial in Beverly Hills (Intergenerational Virtual Paired Exercise,

          Not yet recruiting
          • Social Isolation
          • +2 more
          • Intergenerational Virtual Paired Exercise
          • Peer Virtual Paired Exercise
          • Beverly Hills, California
            Cedars-Sinai Medical Center
          Apr 25, 2023

          Nicotine, Nicotine Vaping, E-cigarette Use Trial in Columbus (Vaping study EC A, Vaping study EC B, Vaping study EC C)

          Not yet recruiting
          • Nicotine
          • +2 more
          • Vaping study EC A
          • +9 more
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          May 9, 2023

          Chronic HBV Infection Trial in Chongqing (PA3670)

          Recruiting
          • Chronic HBV Infection
          • Chongqing, Chongqing, China
            The Second Affiliated Hospital of Chongqing Medical University
          May 6, 2023

          Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Refractory, B-cell Lymphoma Recurrent Trial in São Paulo

          Not yet recruiting
          • Acute Lymphoblastic Leukemia, in Relapse
          • +5 more
          • São Paulo, Brazil
            Hospital Israelita Albert Einstein
          Jan 20, 2023

          Drug Interaction Trial in Beijing (ZX-7101A, Oseltamivir, ZX-7101A and Oseltamivir)

          Recruiting
          • Drug Interaction
          • Beijing, Beijing, China
            Peking University Third Hospital
          Sep 21, 2023

          Phenylketonurias Trial in Bengbu (NGGT002)

          Recruiting
          • Phenylketonurias
          • NGGT002
          • Bengbu, Anhui, China
            The First Affiliated Hospital of Bengbu Medical College
          Sep 25, 2023

          COVID-19, Infectious Disease Trial (JCXH-221, Active Comparator, Placebo)

          Not yet recruiting
          • COVID-19
          • Infectious Disease
          • JCXH-221
          • +2 more
          • (no location specified)
          Feb 22, 2023

          Lymphoma Trial ([14C]SHR2554)

          Not yet recruiting
          • Lymphoma
          • (no location specified)
          Aug 20, 2023

          Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Sumida City (CCX168, Placebo)

          Completed
          • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
          • Sumida City, Tokyo, Japan
            Sumida Hospital, SOUSEIKAI Global Clinical Research Center
          Aug 4, 2023

          QoR-15 for Major Abdominal Surgery

          Not yet recruiting
          • Patients Undergoing Major Abdominal Surgery
            • HsinChu, Taiwan
            • +1 more
            Jul 31, 2023